RB1 and cervical cancer: previously provided evidence that SEPT9 methylation may be a biomarker for the diagnosis of cervical cancer, which functions by promoting tumorigenesis and radiation resistance of cervical cancer by targeting the HMGB1-Rb axis, and induces macrophage polarization by mediating Mir-375.